Dementia and depression with ischemic heart disease: a population-based longitudinal study comparing interventional

W Alan C Mutch1, Randall R Fransoo, Barry I Campbell

  • 1Department of Anesthesia and Peri-operative Medicine, Health Sciences Centre, University of Manitoba, Winnipeg, Manitoba, Canada. amutch@cc.umanitoba.ca

Plos One
|March 10, 2011
PubMed

Insights

Percutaneous coronary intervention (PCI) may reduce dementia risk in ischemic heart disease (IHD) patients. However, both PCI and coronary artery bypass grafting (CABG) increase depression risk compared to medical management.

Area of Science:

  • Cardiology
  • Neurology
  • Public Health

Background:

  • Ischemic heart disease (IHD) patients face risks of dementia and depression.
  • Treatment modalities include percutaneous coronary intervention (PCI), coronary artery bypass grafting (CABG), and medical management.
  • Comparative analysis of neurological outcomes across these IHD treatments is crucial.

Purpose of the Study:

  • To compare the incidence of new dementia and depression diagnoses in IHD patients across PCI, CABG, and medical management groups.
  • To investigate the association between revascularization strategies and subsequent neurological diagnoses.

Main Methods:

  • Retrospective analysis of de-identified administrative health records for 1.1 million individuals in Manitoba, Canada.
  • Patient cohort identified with IHD (ICD-9-CM codes) between 1993-1998.
  • Index events (PCI/CABG) identified between 1998-2003, with follow-up to 2006.
  • Proportional hazards regression analysis adjusting for age, sex, diabetes, and hypertension.

Main Results:

  • Age, sex, diabetes, and hypertension were associated with increased dementia and depression diagnoses.
  • PCI was associated with a lower risk of dementia compared to medical management (HR=0.65, p=0.017).
  • Both PCI (HR=1.25, p=0.028) and CABG (HR=1.32, p=0.0001) showed increased risk of new depression diagnoses compared to medical management.

Conclusions:

  • PCI may offer a protective effect against dementia in IHD patients.
  • Interventional approaches (PCI, CABG) are linked to a higher risk of depression.
  • Further research is needed to elucidate the mechanisms behind PCI's potential dementia-protective effect.
Abstract

Related Concept Videos

Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
Dementia l: Introduction01:22

Dementia l: Introduction

Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...